Clinical Trials for ALX Oncology

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ALX Oncology

Clinical Trials (7)

NCT07085091
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
PHASE1Recruiting
170 participants
Started: Aug 18, 2025 · Completed: Dec 31, 2027
7 conditions1 sponsor4 locations
NCT07007559
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies
PHASE1/PHASE2Recruiting
80 participants
Started: Apr 28, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05467670
Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
PHASE2Recruiting
31 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2031
1 condition3 sponsors1 location
NCT05167409
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
PHASE2Active, not recruiting
48 participants
Started: Jul 28, 2022 · Completed: Mar 1, 2026
1 condition6 sponsors4 locations
NCT05002127
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
PHASE2/PHASE3Active, not recruiting
127 participants
Started: Jan 15, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors83 locations
NCT04675333
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
PHASE2Active, not recruiting
172 participants
Started: May 10, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors44 locations
NCT04675294
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
PHASE2Active, not recruiting
189 participants
Started: Apr 2, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors53 locations